nodes	percent_of_prediction	percent_of_DWPC	metapath
Entecavir—Ascites—Dactinomycin—sarcoma	0.0297	0.0297	CcSEcCtD
Entecavir—Lactic acidosis—Epirubicin—sarcoma	0.0224	0.0224	CcSEcCtD
Entecavir—Transaminases increased—Thiotepa—sarcoma	0.0224	0.0224	CcSEcCtD
Entecavir—Ascites—Etoposide—sarcoma	0.0215	0.0215	CcSEcCtD
Entecavir—Lactic acidosis—Doxorubicin—sarcoma	0.0208	0.0208	CcSEcCtD
Entecavir—Platelet count decreased—Mitoxantrone—sarcoma	0.0197	0.0197	CcSEcCtD
Entecavir—Hepatomegaly—Thiotepa—sarcoma	0.0192	0.0192	CcSEcCtD
Entecavir—Serum creatinine increased—Mitoxantrone—sarcoma	0.0191	0.0191	CcSEcCtD
Entecavir—Hepatomegaly—Dactinomycin—sarcoma	0.0191	0.0191	CcSEcCtD
Entecavir—Laboratory test abnormal—Epirubicin—sarcoma	0.0131	0.0131	CcSEcCtD
Entecavir—Laboratory test abnormal—Doxorubicin—sarcoma	0.0121	0.0121	CcSEcCtD
Entecavir—Ascites—Epirubicin—sarcoma	0.0121	0.0121	CcSEcCtD
Entecavir—Ascites—Doxorubicin—sarcoma	0.0112	0.0112	CcSEcCtD
Entecavir—Hepatic failure—Thiotepa—sarcoma	0.011	0.011	CcSEcCtD
Entecavir—Hepatic failure—Dactinomycin—sarcoma	0.0109	0.0109	CcSEcCtD
Entecavir—Hepatic failure—Vincristine—sarcoma	0.00974	0.00974	CcSEcCtD
Entecavir—Blood creatinine increased—Thiotepa—sarcoma	0.00925	0.00925	CcSEcCtD
Entecavir—Transaminases increased—Epirubicin—sarcoma	0.009	0.009	CcSEcCtD
Entecavir—Serum creatinine increased—Epirubicin—sarcoma	0.0089	0.0089	CcSEcCtD
Entecavir—Anaphylactoid reaction—Mitoxantrone—sarcoma	0.00881	0.00881	CcSEcCtD
Entecavir—Transaminases increased—Doxorubicin—sarcoma	0.00833	0.00833	CcSEcCtD
Entecavir—Serum creatinine increased—Doxorubicin—sarcoma	0.00824	0.00824	CcSEcCtD
Entecavir—Blood creatinine increased—Mitoxantrone—sarcoma	0.00799	0.00799	CcSEcCtD
Entecavir—Neutropenia—Dactinomycin—sarcoma	0.00792	0.00792	CcSEcCtD
Entecavir—Abdominal pain upper—Mitoxantrone—sarcoma	0.00779	0.00779	CcSEcCtD
Entecavir—Hepatomegaly—Epirubicin—sarcoma	0.00774	0.00774	CcSEcCtD
Entecavir—Hyperglycaemia—Thiotepa—sarcoma	0.0077	0.0077	CcSEcCtD
Entecavir—Renal failure—Thiotepa—sarcoma	0.00748	0.00748	CcSEcCtD
Entecavir—Anaphylactoid reaction—Etoposide—sarcoma	0.00733	0.00733	CcSEcCtD
Entecavir—Haematuria—Thiotepa—sarcoma	0.00725	0.00725	CcSEcCtD
Entecavir—Hepatobiliary disease—Thiotepa—sarcoma	0.0072	0.0072	CcSEcCtD
Entecavir—Hepatomegaly—Doxorubicin—sarcoma	0.00716	0.00716	CcSEcCtD
Entecavir—Neutropenia—Vincristine—sarcoma	0.00708	0.00708	CcSEcCtD
Entecavir—Neutropenia—Mitoxantrone—sarcoma	0.00689	0.00689	CcSEcCtD
Entecavir—Upper respiratory tract infection—Mitoxantrone—sarcoma	0.00685	0.00685	CcSEcCtD
Entecavir—Hepatitis—Dactinomycin—sarcoma	0.00678	0.00678	CcSEcCtD
Entecavir—Glycosuria—Epirubicin—sarcoma	0.00676	0.00676	CcSEcCtD
Entecavir—Hyperglycaemia—Mitoxantrone—sarcoma	0.00665	0.00665	CcSEcCtD
Entecavir—Renal failure—Mitoxantrone—sarcoma	0.00646	0.00646	CcSEcCtD
Entecavir—Haematuria—Mitoxantrone—sarcoma	0.00626	0.00626	CcSEcCtD
Entecavir—Glycosuria—Doxorubicin—sarcoma	0.00625	0.00625	CcSEcCtD
Entecavir—Immune system disorder—Thiotepa—sarcoma	0.00617	0.00617	CcSEcCtD
Entecavir—Alopecia—Thiotepa—sarcoma	0.00604	0.00604	CcSEcCtD
Entecavir—Alopecia—Dactinomycin—sarcoma	0.00599	0.00599	CcSEcCtD
Entecavir—Mental disorder—Thiotepa—sarcoma	0.00598	0.00598	CcSEcCtD
Entecavir—Malnutrition—Thiotepa—sarcoma	0.00595	0.00595	CcSEcCtD
Entecavir—Hepatitis—Mitoxantrone—sarcoma	0.0059	0.0059	CcSEcCtD
Entecavir—Neutropenia—Etoposide—sarcoma	0.00573	0.00573	CcSEcCtD
Entecavir—Renal failure—Etoposide—sarcoma	0.00537	0.00537	CcSEcCtD
Entecavir—Alopecia—Vincristine—sarcoma	0.00535	0.00535	CcSEcCtD
Entecavir—Leukopenia—Thiotepa—sarcoma	0.00532	0.00532	CcSEcCtD
Entecavir—Mental disorder—Vincristine—sarcoma	0.00531	0.00531	CcSEcCtD
Entecavir—Leukopenia—Dactinomycin—sarcoma	0.00528	0.00528	CcSEcCtD
Entecavir—Alopecia—Mitoxantrone—sarcoma	0.00521	0.00521	CcSEcCtD
Entecavir—Hepatobiliary disease—Etoposide—sarcoma	0.00517	0.00517	CcSEcCtD
Entecavir—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—sarcoma	0.00503	0.00503	CcSEcCtD
Entecavir—Infection—Thiotepa—sarcoma	0.00482	0.00482	CcSEcCtD
Entecavir—Infection—Dactinomycin—sarcoma	0.00478	0.00478	CcSEcCtD
Entecavir—Nervous system disorder—Thiotepa—sarcoma	0.00476	0.00476	CcSEcCtD
Entecavir—Leukopenia—Vincristine—sarcoma	0.00472	0.00472	CcSEcCtD
Entecavir—Skin disorder—Thiotepa—sarcoma	0.00471	0.00471	CcSEcCtD
Entecavir—Leukopenia—Mitoxantrone—sarcoma	0.0046	0.0046	CcSEcCtD
Entecavir—Immune system disorder—Etoposide—sarcoma	0.00443	0.00443	CcSEcCtD
Entecavir—Hepatic failure—Epirubicin—sarcoma	0.00442	0.00442	CcSEcCtD
Entecavir—Alopecia—Etoposide—sarcoma	0.00434	0.00434	CcSEcCtD
Entecavir—Somnolence—Thiotepa—sarcoma	0.00431	0.00431	CcSEcCtD
Entecavir—Anaphylactic shock—Vincristine—sarcoma	0.0043	0.0043	CcSEcCtD
Entecavir—Infection—Vincristine—sarcoma	0.00427	0.00427	CcSEcCtD
Entecavir—Dyspepsia—Thiotepa—sarcoma	0.00427	0.00427	CcSEcCtD
Entecavir—Nervous system disorder—Vincristine—sarcoma	0.00422	0.00422	CcSEcCtD
Entecavir—Anaphylactic shock—Mitoxantrone—sarcoma	0.00419	0.00419	CcSEcCtD
Entecavir—Gastrointestinal disorder—Thiotepa—sarcoma	0.00419	0.00419	CcSEcCtD
Entecavir—Fatigue—Thiotepa—sarcoma	0.00418	0.00418	CcSEcCtD
Entecavir—Infection—Mitoxantrone—sarcoma	0.00416	0.00416	CcSEcCtD
Entecavir—Fatigue—Dactinomycin—sarcoma	0.00415	0.00415	CcSEcCtD
Entecavir—Anaphylactoid reaction—Epirubicin—sarcoma	0.00411	0.00411	CcSEcCtD
Entecavir—Hepatic failure—Doxorubicin—sarcoma	0.00409	0.00409	CcSEcCtD
Entecavir—Skin disorder—Mitoxantrone—sarcoma	0.00407	0.00407	CcSEcCtD
Entecavir—Gastrointestinal pain—Thiotepa—sarcoma	0.00397	0.00397	CcSEcCtD
Entecavir—Gastrointestinal pain—Dactinomycin—sarcoma	0.00394	0.00394	CcSEcCtD
Entecavir—Insomnia—Vincristine—sarcoma	0.00389	0.00389	CcSEcCtD
Entecavir—Abdominal pain—Thiotepa—sarcoma	0.00384	0.00384	CcSEcCtD
Entecavir—Body temperature increased—Thiotepa—sarcoma	0.00384	0.00384	CcSEcCtD
Entecavir—Leukopenia—Etoposide—sarcoma	0.00382	0.00382	CcSEcCtD
Entecavir—Abdominal pain—Dactinomycin—sarcoma	0.00381	0.00381	CcSEcCtD
Entecavir—Body temperature increased—Dactinomycin—sarcoma	0.00381	0.00381	CcSEcCtD
Entecavir—Anaphylactoid reaction—Doxorubicin—sarcoma	0.0038	0.0038	CcSEcCtD
Entecavir—Somnolence—Mitoxantrone—sarcoma	0.00373	0.00373	CcSEcCtD
Entecavir—Blood creatinine increased—Epirubicin—sarcoma	0.00372	0.00372	CcSEcCtD
Entecavir—Gastrointestinal disorder—Vincristine—sarcoma	0.00371	0.00371	CcSEcCtD
Entecavir—Fatigue—Vincristine—sarcoma	0.00371	0.00371	CcSEcCtD
Entecavir—Dyspepsia—Mitoxantrone—sarcoma	0.00369	0.00369	CcSEcCtD
Entecavir—Abdominal pain upper—Epirubicin—sarcoma	0.00363	0.00363	CcSEcCtD
Entecavir—Fatigue—Mitoxantrone—sarcoma	0.00361	0.00361	CcSEcCtD
Entecavir—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.00361	0.00361	CcSEcCtD
Entecavir—Gastrointestinal pain—Vincristine—sarcoma	0.00352	0.00352	CcSEcCtD
Entecavir—Anaphylactic shock—Etoposide—sarcoma	0.00349	0.00349	CcSEcCtD
Entecavir—Asthenia—Thiotepa—sarcoma	0.00348	0.00348	CcSEcCtD
Entecavir—Infection—Etoposide—sarcoma	0.00346	0.00346	CcSEcCtD
Entecavir—Asthenia—Dactinomycin—sarcoma	0.00346	0.00346	CcSEcCtD
Entecavir—Blood creatinine increased—Doxorubicin—sarcoma	0.00345	0.00345	CcSEcCtD
Entecavir—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00343	0.00343	CcSEcCtD
Entecavir—Body temperature increased—Vincristine—sarcoma	0.0034	0.0034	CcSEcCtD
Entecavir—Abdominal pain—Vincristine—sarcoma	0.0034	0.0034	CcSEcCtD
Entecavir—Skin disorder—Etoposide—sarcoma	0.00339	0.00339	CcSEcCtD
Entecavir—Pancreatitis—Epirubicin—sarcoma	0.00337	0.00337	CcSEcCtD
Entecavir—Abdominal pain upper—Doxorubicin—sarcoma	0.00336	0.00336	CcSEcCtD
Entecavir—Diarrhoea—Thiotepa—sarcoma	0.00332	0.00332	CcSEcCtD
Entecavir—Abdominal pain—Mitoxantrone—sarcoma	0.00331	0.00331	CcSEcCtD
Entecavir—Body temperature increased—Mitoxantrone—sarcoma	0.00331	0.00331	CcSEcCtD
Entecavir—Diarrhoea—Dactinomycin—sarcoma	0.0033	0.0033	CcSEcCtD
Entecavir—Neutropenia—Epirubicin—sarcoma	0.00321	0.00321	CcSEcCtD
Entecavir—Dizziness—Thiotepa—sarcoma	0.00321	0.00321	CcSEcCtD
Entecavir—Upper respiratory tract infection—Epirubicin—sarcoma	0.00319	0.00319	CcSEcCtD
Entecavir—Pancreatitis—Doxorubicin—sarcoma	0.00312	0.00312	CcSEcCtD
Entecavir—Hyperglycaemia—Epirubicin—sarcoma	0.0031	0.0031	CcSEcCtD
Entecavir—Somnolence—Etoposide—sarcoma	0.0031	0.0031	CcSEcCtD
Entecavir—Asthenia—Vincristine—sarcoma	0.00309	0.00309	CcSEcCtD
Entecavir—Vomiting—Thiotepa—sarcoma	0.00309	0.00309	CcSEcCtD
Entecavir—Vomiting—Dactinomycin—sarcoma	0.00306	0.00306	CcSEcCtD
Entecavir—Rash—Thiotepa—sarcoma	0.00306	0.00306	CcSEcCtD
Entecavir—Dermatitis—Thiotepa—sarcoma	0.00306	0.00306	CcSEcCtD
Entecavir—Headache—Thiotepa—sarcoma	0.00304	0.00304	CcSEcCtD
Entecavir—Rash—Dactinomycin—sarcoma	0.00304	0.00304	CcSEcCtD
Entecavir—Renal failure—Epirubicin—sarcoma	0.00301	0.00301	CcSEcCtD
Entecavir—Gastrointestinal disorder—Etoposide—sarcoma	0.00301	0.00301	CcSEcCtD
Entecavir—Asthenia—Mitoxantrone—sarcoma	0.00301	0.00301	CcSEcCtD
Entecavir—Fatigue—Etoposide—sarcoma	0.00301	0.00301	CcSEcCtD
Entecavir—Neutropenia—Doxorubicin—sarcoma	0.00297	0.00297	CcSEcCtD
Entecavir—Upper respiratory tract infection—Doxorubicin—sarcoma	0.00295	0.00295	CcSEcCtD
Entecavir—Diarrhoea—Vincristine—sarcoma	0.00294	0.00294	CcSEcCtD
Entecavir—Haematuria—Epirubicin—sarcoma	0.00292	0.00292	CcSEcCtD
Entecavir—Hepatobiliary disease—Epirubicin—sarcoma	0.0029	0.0029	CcSEcCtD
Entecavir—Nausea—Thiotepa—sarcoma	0.00288	0.00288	CcSEcCtD
Entecavir—Hyperglycaemia—Doxorubicin—sarcoma	0.00287	0.00287	CcSEcCtD
Entecavir—Diarrhoea—Mitoxantrone—sarcoma	0.00287	0.00287	CcSEcCtD
Entecavir—Nausea—Dactinomycin—sarcoma	0.00286	0.00286	CcSEcCtD
Entecavir—Gastrointestinal pain—Etoposide—sarcoma	0.00285	0.00285	CcSEcCtD
Entecavir—Dizziness—Vincristine—sarcoma	0.00285	0.00285	CcSEcCtD
Entecavir—Renal failure—Doxorubicin—sarcoma	0.00279	0.00279	CcSEcCtD
Entecavir—Abdominal pain—Etoposide—sarcoma	0.00276	0.00276	CcSEcCtD
Entecavir—Body temperature increased—Etoposide—sarcoma	0.00276	0.00276	CcSEcCtD
Entecavir—Hepatitis—Epirubicin—sarcoma	0.00275	0.00275	CcSEcCtD
Entecavir—Vomiting—Vincristine—sarcoma	0.00274	0.00274	CcSEcCtD
Entecavir—Rash—Vincristine—sarcoma	0.00271	0.00271	CcSEcCtD
Entecavir—Dermatitis—Vincristine—sarcoma	0.00271	0.00271	CcSEcCtD
Entecavir—Oedema peripheral—Epirubicin—sarcoma	0.00271	0.00271	CcSEcCtD
Entecavir—Haematuria—Doxorubicin—sarcoma	0.0027	0.0027	CcSEcCtD
Entecavir—Headache—Vincristine—sarcoma	0.0027	0.0027	CcSEcCtD
Entecavir—Hepatobiliary disease—Doxorubicin—sarcoma	0.00268	0.00268	CcSEcCtD
Entecavir—Vomiting—Mitoxantrone—sarcoma	0.00266	0.00266	CcSEcCtD
Entecavir—Rash—Mitoxantrone—sarcoma	0.00264	0.00264	CcSEcCtD
Entecavir—Dermatitis—Mitoxantrone—sarcoma	0.00264	0.00264	CcSEcCtD
Entecavir—Headache—Mitoxantrone—sarcoma	0.00263	0.00263	CcSEcCtD
Entecavir—Nausea—Vincristine—sarcoma	0.00256	0.00256	CcSEcCtD
Entecavir—Hepatitis—Doxorubicin—sarcoma	0.00254	0.00254	CcSEcCtD
Entecavir—Oedema peripheral—Doxorubicin—sarcoma	0.00251	0.00251	CcSEcCtD
Entecavir—Asthenia—Etoposide—sarcoma	0.0025	0.0025	CcSEcCtD
Entecavir—Nausea—Mitoxantrone—sarcoma	0.00249	0.00249	CcSEcCtD
Entecavir—Immune system disorder—Epirubicin—sarcoma	0.00248	0.00248	CcSEcCtD
Entecavir—Alopecia—Epirubicin—sarcoma	0.00243	0.00243	CcSEcCtD
Entecavir—Mental disorder—Epirubicin—sarcoma	0.00241	0.00241	CcSEcCtD
Entecavir—Malnutrition—Epirubicin—sarcoma	0.00239	0.00239	CcSEcCtD
Entecavir—Diarrhoea—Etoposide—sarcoma	0.00238	0.00238	CcSEcCtD
Entecavir—Dizziness—Etoposide—sarcoma	0.0023	0.0023	CcSEcCtD
Entecavir—Immune system disorder—Doxorubicin—sarcoma	0.0023	0.0023	CcSEcCtD
Entecavir—Alopecia—Doxorubicin—sarcoma	0.00225	0.00225	CcSEcCtD
Entecavir—Mental disorder—Doxorubicin—sarcoma	0.00223	0.00223	CcSEcCtD
Entecavir—Vomiting—Etoposide—sarcoma	0.00222	0.00222	CcSEcCtD
Entecavir—Malnutrition—Doxorubicin—sarcoma	0.00222	0.00222	CcSEcCtD
Entecavir—Rash—Etoposide—sarcoma	0.0022	0.0022	CcSEcCtD
Entecavir—Dermatitis—Etoposide—sarcoma	0.0022	0.0022	CcSEcCtD
Entecavir—Headache—Etoposide—sarcoma	0.00218	0.00218	CcSEcCtD
Entecavir—Leukopenia—Epirubicin—sarcoma	0.00214	0.00214	CcSEcCtD
Entecavir—Nausea—Etoposide—sarcoma	0.00207	0.00207	CcSEcCtD
Entecavir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.00202	0.00202	CcSEcCtD
Entecavir—Leukopenia—Doxorubicin—sarcoma	0.00198	0.00198	CcSEcCtD
Entecavir—Anaphylactic shock—Epirubicin—sarcoma	0.00195	0.00195	CcSEcCtD
Entecavir—Infection—Epirubicin—sarcoma	0.00194	0.00194	CcSEcCtD
Entecavir—Nervous system disorder—Epirubicin—sarcoma	0.00192	0.00192	CcSEcCtD
Entecavir—Skin disorder—Epirubicin—sarcoma	0.0019	0.0019	CcSEcCtD
Entecavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.00187	0.00187	CcSEcCtD
Entecavir—Anaphylactic shock—Doxorubicin—sarcoma	0.00181	0.00181	CcSEcCtD
Entecavir—Infection—Doxorubicin—sarcoma	0.0018	0.0018	CcSEcCtD
Entecavir—Nervous system disorder—Doxorubicin—sarcoma	0.00177	0.00177	CcSEcCtD
Entecavir—Insomnia—Epirubicin—sarcoma	0.00177	0.00177	CcSEcCtD
Entecavir—Skin disorder—Doxorubicin—sarcoma	0.00176	0.00176	CcSEcCtD
Entecavir—Somnolence—Epirubicin—sarcoma	0.00174	0.00174	CcSEcCtD
Entecavir—Dyspepsia—Epirubicin—sarcoma	0.00172	0.00172	CcSEcCtD
Entecavir—Gastrointestinal disorder—Epirubicin—sarcoma	0.00169	0.00169	CcSEcCtD
Entecavir—Fatigue—Epirubicin—sarcoma	0.00168	0.00168	CcSEcCtD
Entecavir—Insomnia—Doxorubicin—sarcoma	0.00164	0.00164	CcSEcCtD
Entecavir—Somnolence—Doxorubicin—sarcoma	0.00161	0.00161	CcSEcCtD
Entecavir—Gastrointestinal pain—Epirubicin—sarcoma	0.0016	0.0016	CcSEcCtD
Entecavir—Dyspepsia—Doxorubicin—sarcoma	0.00159	0.00159	CcSEcCtD
Entecavir—Gastrointestinal disorder—Doxorubicin—sarcoma	0.00156	0.00156	CcSEcCtD
Entecavir—Fatigue—Doxorubicin—sarcoma	0.00156	0.00156	CcSEcCtD
Entecavir—Abdominal pain—Epirubicin—sarcoma	0.00154	0.00154	CcSEcCtD
Entecavir—Body temperature increased—Epirubicin—sarcoma	0.00154	0.00154	CcSEcCtD
Entecavir—Gastrointestinal pain—Doxorubicin—sarcoma	0.00148	0.00148	CcSEcCtD
Entecavir—Body temperature increased—Doxorubicin—sarcoma	0.00143	0.00143	CcSEcCtD
Entecavir—Abdominal pain—Doxorubicin—sarcoma	0.00143	0.00143	CcSEcCtD
Entecavir—Asthenia—Epirubicin—sarcoma	0.0014	0.0014	CcSEcCtD
Entecavir—Diarrhoea—Epirubicin—sarcoma	0.00134	0.00134	CcSEcCtD
Entecavir—Asthenia—Doxorubicin—sarcoma	0.0013	0.0013	CcSEcCtD
Entecavir—Dizziness—Epirubicin—sarcoma	0.00129	0.00129	CcSEcCtD
Entecavir—Vomiting—Epirubicin—sarcoma	0.00124	0.00124	CcSEcCtD
Entecavir—Diarrhoea—Doxorubicin—sarcoma	0.00124	0.00124	CcSEcCtD
Entecavir—Rash—Epirubicin—sarcoma	0.00123	0.00123	CcSEcCtD
Entecavir—Dermatitis—Epirubicin—sarcoma	0.00123	0.00123	CcSEcCtD
Entecavir—Headache—Epirubicin—sarcoma	0.00122	0.00122	CcSEcCtD
Entecavir—Dizziness—Doxorubicin—sarcoma	0.0012	0.0012	CcSEcCtD
Entecavir—Nausea—Epirubicin—sarcoma	0.00116	0.00116	CcSEcCtD
Entecavir—Vomiting—Doxorubicin—sarcoma	0.00115	0.00115	CcSEcCtD
Entecavir—Rash—Doxorubicin—sarcoma	0.00114	0.00114	CcSEcCtD
Entecavir—Dermatitis—Doxorubicin—sarcoma	0.00114	0.00114	CcSEcCtD
Entecavir—Headache—Doxorubicin—sarcoma	0.00113	0.00113	CcSEcCtD
Entecavir—Nausea—Doxorubicin—sarcoma	0.00107	0.00107	CcSEcCtD
